Onxeo
Records under this name other than patents Onxeo holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,791,127 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,747,896 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,211,466 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,592,434 | Mucoadhesive Buccal Tablets for the Treatment of Orofacial Herpes Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,428,538 | Optimized in Vivo Delivery System with Endosomolytic Agents for Nucleic Acid Conjugates Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,363,317 | Optimized in Vivo Delivery System with Endosomolytic Agents for Nucleic Acid Conjugates Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,765,758 | Optimized in Vivo Delivery System with Endosomolytic Agents for Nucleic Acid Conjugates Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,563,197 | Use of a Combination of Dbait Molecule and Parp Inhibitors to Treat Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 10,821,128 | Treatment of Cancer by Systemic Administration of Dbait Molecules Formerly held In force · High confidence | In force | High confidence | |
| US 11,266,614 | Oral formulations of belinostat Formerly held In force · From the USPTO record | In force | From the USPTO record |